Article Details

Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 ...

Retrieved on: 2022-06-05 15:31:59

Tags for this article:

Click the tags to see associated articles and topics

Eisai Presents New Findings for Antibody Drug Conjugate Farletuzumab Ecteribulin at 2022 .... View article details on hiswai:

Excerpt

Farletuzumab ecteribulin is composed of Eisai's in-house developed farletuzumab, a humanized IgG1 monoclonal antibody that binds to the folate ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up